Bortezomib-induced lung toxicity.
Sección de Neumología, Hospital de Monforte de Lemos, Monforte de Lemos, Lugo, España. Electronic address: marussantalla@gmail.com.
Mariluz
M
Santalla Martínez
Servicio de Neumología, Complexo Hospitalario de Ourense, Ourense, España.
Nagore
N
Blanco Cid
Servicio de Neumología, Complexo Hospitalario de Ourense, Ourense, España.
Raquel
R
Dacal Quintas
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001897:Boronic Acids / Q000009:adverse effects*; D000069286:Bortezomib; D003907:Dexamethasone / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D057915:Drug Substitution; D005260:Female; D006801:Humans; D000077269:Lenalidomide; D008171:Lung Diseases / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D009101:Multiple Myeloma / Q000188:drug therapy; D011719:Pyrazines / Q000009:adverse effects*; D013147:Spirometry; D013792:Thalidomide / Q000008:administration & dosage / Q000031:analogs & derivatives
D001897:Boronic Acids; D011719:Pyrazines; D013792:Thalidomide; D000069286:Bortezomib; D003907:Dexamethasone; D004317:Doxorubicin; D000077269:Lenalidomide